21.94 USD
↗ 0.01 (0.07%)PRE MARKET (AS OF 07:31 PM EDT)
Nuvectis Pharma, Inc. Common Stock
NVCTNASDAQ • USD
Market: OPEN
Shares of Nuvectis Pharma, Inc. Common Stock (NVCT) are trading at $21.94. Our models show a "Sell" technical signal alongside a "Neutral" fundamental rating. Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Furthermore, NVCT is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Sep 15, 2026.
Open?$23.00
High?$23.61
Low?$21.82
Prev. Close?$21.92
Volume?142.3K
Avg. Volume?202.6K
VWAP?$22.22
Rel. Volume?0.70x
Bid / Ask
Bid?$18.61 × 100
Ask?$26.85 × 100
Spread?$8.24
Midpoint?$22.73
Valuation & Ratios
Market Cap?715.6M
Shares Out?32.6M
Float?22.1M
Float %?67.8%
P/E Ratio?N/A
P/B Ratio?78.79
EPS?-$0.93
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.
Themes
Employees
13
Market Cap
762.2M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2022-02-04
Address
1 BRIDGE PLAZA, SUITE 275
FORT LEE, NJ 07024
Phone: 360-837-7232
FORT LEE, NJ 07024
Phone: 360-837-7232
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?100
Momentum?50
Short Sent.?24
Piotroski F-Score?0/9Weak
Altman Z-Score?21.47Safe
Confidence?48%Low
Short InterestHigh
Short % of Float?9.94%Elevated
Short Interest?2.2M
Days to Cover?9.3
Free Float22.1M
Avg Daily Volume235.5K
Settlement Date2026-08-31
Financial Health
Current Ratio?1.68Adequate
Quick Ratio?1.68Adequate
Cash Ratio?1.67Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?78.79HIGH▾
Peers100
S&P3
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-24.0CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-333.3%WEAK▾
S&P3
ROA?-135.3%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-19510000
Enterprise Value?$693.4M
Fundamentals ratios updated end of day